NEUROCARE GROUP

neurocare is active in the fast-growing market for neurotherapy, ​​a non-invasive option for mental health, pain and rehabilitation using neuromodulation technologies integrated with psychotherapy. By measuring and modulating brain activity we help clinicians and patients to achieve significant and lasting therapeutic outcomes. We are further specialized in applying neuromodulation techniques (such as QEEG assessments) to improve diagnostics for choosing the right therapy (prognostics). This allows us to personalize treatment to the patient's needs... neurocare offers treatment for psychiatric disorders, pain management and rehabilitation via its international network of neurocare clinics. At our neurocare academy we educate professionals, researchers and clinicians in the area of neuromodulation techniques supported by industry-leading technology... At neurocare, our therapists are trained to use these tools and have been supervised by leading neuroscientists and practitioners to..

Also known as: neurocare, neurocare group AG, neuroCare Group America, Inc., neuroCare Group GmbH, neuroCare Group Pty Ltd

Registration numbers: HRB 516 212 (W), HRB 517 998 (W)

VAT numbers: DE 295 572 011

Primary location: Medford United States